Prevalence of monogenic diabetes in the population-based Norwegian Childhood Diabetes Registry

Diabetologia

Volumn 56, Issue 7, 2013, Pages 1512-1519

  Irgens, H U ^a,b   Molnes, J ^a,b   Johansson, B B ^a,b   Ringdal, M ^a,b   Skrivarhaug, T ^c   Undlien, D E ^c   Sovik O ^a   Joner, G ^c,d   Molven, A ^a,e   Njolstad P R ^a,b,f  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e HARVARD MEDICAL SCHOOL   (United States)

^f MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Genetic screening; MODY; Monogenic diabetes; Permanent neonatal diabetes mellitus; Prevalence

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE;

ABCC8 GENE; ADOLESCENT; ARTICLE; CHILD; DIABETES MELLITUS; DISEASE REGISTRY; FEMALE; GCK GENE; GENE; GENE MUTATION; GENETIC SCREENING; HNF1A GENE; HNF4A GENE; HUMAN; INFANT; INS GENE; KCNJ11 GENE; MAJOR CLINICAL STUDY; MALE; MONOGENIC DISORDER; MT TL1 GENE; NUCLEOTIDE SEQUENCE; ONSET AGE; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCOKINASE; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; INFANT; INFANT, NEWBORN; MALE; MUTATION; POTASSIUM CHANNELS, INWARDLY RECTIFYING; REGISTRIES; SULFONYLUREA RECEPTORS;

EID: 84878853427     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-2916-y     Document Type: Article

References (34)

1. Molven A, Njolstad PR (2011) Role of molecular genetics in transforming diagnosis of diabetes mellitus. Expert Rev Mol Diagn 11:313-320
2. Vaxillaire M, Bonnefond A, Froguel P (2012) The lessons of early-onset monogenic diabetes for the understanding of diabetes pathogenesis. Best Pract Res Clin Endocrinol Metab 26:171-187
3. Gloyn AL, Pearson ER, Antcliff JF et al (2004) Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 350:1838-1849
4. Babenko AP, Polak M, Cave H et al (2006) Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med 355:456-466
5. Stoy J, Steiner DF, Park SY, Ye H, Philipson LH, Bell GI (2010) Clinical and molecular genetics of neonatal diabetes due to mutations in the insulin gene. Rev Endocr Metab Disord 11:205-215
6. Habeb AM, Flanagan SE, Deeb A et al (2012) Permanent neonatal diabetes: different aetiology in Arabs compared to Europeans. Arch Dis Child 97:721-723
7. Bonnefond A, Philippe J, Durand E et al (2012) Whole-exome sequencing and high throughput genotyping identified KCNJ11 as the thirteenth MODY gene. PLoS One 7:e37423
8. Shields BM, Hicks S, Shepherd MH, Colclough K, Hattersley AT, Ellard S (2010) Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 53:2504-2508
9. Estalella I, Rica I, Perez de Nanclares G et al (2007) Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain. Clin Endocrinol 67:538-546
10. Schober E, Rami B, Grabert M et al (2009) Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database. Diabet Med J Br Diabet Assoc 26:466-473
11. Page RC, Hattersley AT, Levy JC et al (1995) Clinical characteristics of subjects with a missense mutation in glucokinase. Diabet Med J Br Diabet Assoc 12:209-217
12. Shepherd M, Shields B, Ellard S, Rubio-Cabezas O, Hattersley AT (2009) A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients. Diabet Med J Br Diabet Assoc 26:437-441
13. Isomaa B, Henricsson M, Lehto M et al (1998) Chronic diabetic complications in patients with MODY3 diabetes. Diabetologia 41:467-473
14. Bellanne-Chantelot C, Chauveau D, Gautier JF et al (2004) Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations. Ann Intern Med 140:510-517
15. Oram RA, Edghill EL, Blackman J et al (2010) Mutations in the hepatocyte nuclear factor-1β (HNF1B) gene are common with combined uterine and renal malformations but are not found with isolated uterine malformations. Am J Obstet Gynecol 203(364):e1-e5
16. Raeder H, Johansson S, Holm PI et al (2006) Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nat Genet 38:54-62
17. Haldorsen IS, Raeder H, Vesterhus M, Molven A, Njolstad PR (2012) The role of pancreatic imaging in monogenic diabetes mellitus. Nat Rev Endocrinol 8:148-159
18. Murphy R, Turnbull DM, Walker M, Hattersley AT (2008) Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation. Diabet Med J Br Diabet Assoc 25:383-399
19. Tsukuda K, Suzuki Y, Kameoka K et al (1997) Screening of patients with maternally transmitted diabetes for mitochondrial gene mutations in the tRNA[Leu(UUR)] region. Diabet Med J Br Diabet Assoc 14:1032-1037
20. Iafusco D, Massa O, Pasquino B et al (2012) Minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90,000 live births. Acta Diabetol 49:405-408
21. Stanik J, Gasperikova D, Paskova M et al (2007) Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers. J Clin Endocrinol Metab 92:1276-1282
22. Slingerland AS, Shields BM, Flanagan SE et al (2009) Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260,000 live births. Diabetologia 52:1683-1685
23. Shankar RK, Pihoker C, Dolan LM et al (2012) Permanent neonatal diabetes mellitus: prevalence and genetic diagnosis in the SEARCH for Diabetes in Youth Study. Pediatr Diabetes. doi: 10.1111/pedi.12003
24. Wiedemann B, Schober E, Waldhoer T et al (2010) Incidence of neonatal diabetes in Austria - calculation based on the Austrian Diabetes Register. Pediatr Diabetes 11:18-23
25. Eide SA, Raeder H, Johansson S et al (2008) Prevalence of HNF1A (MODY3) mutations in a Norwegian population (the HUNT2 Study). Diabet Med J Br Diabet Assoc 25:775-781
26. Kropff J, Selwood MP, McCarthy MI, Farmer AJ, Owen KR (2011) Prevalence of monogenic diabetes in young adults: a community-based, cross-sectional study in Oxfordshire, UK. Diabetologia 54:1261-1263
27. Fendler W, Borowiec M, Baranowska-Jazwiecka A et al (2012) Prevalence of monogenic diabetes amongst Polish children after a nationwide genetic screening campaign. Diabetologia 55:2631-2635
28. Sagen JV, Raeder H, Hathout E et al (2004) Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. Diabetes 53:2713-2718
29. Pearson ER, Flechtner I, Njolstad PR et al (2006) Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 355:467-477
30. Garin I, Perez de Nanclares G, Gastaldo E, Harries LW, Rubio-Cabezas O, Castano L (2012) Permanent neonatal diabetes caused by creation of an ectopic splice site within the INS gene. PLoS One 7:e29205
31. Sandal T, Laborie LB, Brusgaard K et al (2009) The spectrum of ABCC8 mutations in Norwegian patients with congenital hyperinsulinism of infancy. Clin Genet 75:440-448
32. Carette C, Dubois-Laforgue D, Saint-Martin C et al (2010) Familial young-onset forms of diabetes related to HNF4A and rare HNF1A molecular aetiologies. Diabet Med J Br Diabet Assoc 27:1454-1458
33. Schlosser M, Strebelow M, Wassmuth R et al (2002) The Karlsburg type 1 diabetes risk study of a normal schoolchild population: association of beta-cell autoantibodies and human leukocyte antigen-DQB1 alleles in antibody-positive individuals. J Clin Endocrinol Metab 87:2254-2261
34. Johansson S, Irgens H, Chudasama KK et al (2012) Exome sequencing and genetic testing for MODY. PLoS One 7:e38050